• 649 Citations
  • 11 Scopus h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1997 2019

  • 649 Citations
  • 11 Scopus h-Index
  • 34 Article
  • 6 Letter
  • 1 Comment/debate
Filter
Letter
2019
1 Citation (Scopus)

False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms

King, R., McPhail, E., Meyer, R. G., Vasmatzis, G., Pearce, K., Smadbeck, J., Ketterling, R. P., Smoley, S. A., Greipp, P. T., Hoppman, N. L., Peterson, J. F. & Baughn, L., Jun 1 2019, In : Haematologica. 104, 6, p. e248-e251

Research output: Contribution to journalLetter

Fluorescence In Situ Hybridization
B-Lymphocytes
Neoplasms
2 Citations (Scopus)

Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations

Peterson, J. F., Rowsey, R. A., Marcou, C. A., Pearce, K. E., Williamson, C. M., Frederick, L. A., Greipp, P. T., Ketterling, R. P., Kumar, S. K., Viswanatha, D. S., Polley, M-Y., Fink, J. M., Reichard, K. K., Van Dyke, D. L. & Baughn, L., Mar 1 2019, In : Blood cancer journal. 9, 3, 20.

Research output: Contribution to journalLetter

Monosomy
Multiple Myeloma
Mutation

Identification of a Novel ZBTB20-JAK2 Fusion by Mate-Pair Sequencing in a Young Adult With B-Lymphoblastic Leukemia/Lymphoma

Peterson, J. F., Blackburn, P. R., Webley, M. R., Pearce, K. E., Williamson, C. M., Vasmatzis, G., Smadbeck, J., Bieliauskas, S. L., Reichard, K. K., Ketterling, R. P., Baughn, L. & Greipp, P. T., Jul 1 2019, In : Mayo Clinic proceedings. 94, 7, p. 1381-1384 4 p.

Research output: Contribution to journalLetter

Open Access
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Young Adult
Tetraploidy
Multiple Myeloma
2014

Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

Stessman, H. A. F., Mansoor, A., Linden, M. A., Van Ness, B. & Baughn, L., Jan 1 2014, In : Leukemia and Lymphoma. 55, 1, p. 220-222 3 p.

Research output: Contribution to journalLetter

Neoplasm Drug Resistance
Boronic Acids
Cytidine Deaminase
Pyrazines
Enzyme Activation
2013
26 Citations (Scopus)

Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

Stessman, H. A. F., Mansoor, A., Zhan, F., Janz, S., Linden, M. A., Baughn, L. & Van Ness, B., Oct 1 2013, In : Leukemia. 27, 10, p. 2075-2077 3 p.

Research output: Contribution to journalLetter

Neoplasm Drug Resistance
Boronic Acids
Myeloid Sarcoma
CXCR4 Receptors
Pyrazines